rs2071627

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_148919.4(PSMB8):​c.742+85G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.395 in 1,392,178 control chromosomes in the GnomAD database, including 111,468 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 10304 hom., cov: 32)
Exomes 𝑓: 0.40 ( 101164 hom. )

Consequence

PSMB8
NM_148919.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0200

Publications

8 publications found
Variant links:
Genes affected
PSMB8 (HGNC:9545): (proteasome 20S subunit beta 8) The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. [provided by RefSeq, Jul 2008]
PSMB8 Gene-Disease associations (from GenCC):
  • proteasome-associated autoinflammatory syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • proteosome-associated autoinflammatory syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 6-32841446-C-A is Benign according to our data. Variant chr6-32841446-C-A is described in ClinVar as Benign. ClinVar VariationId is 1239292.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.411 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PSMB8NM_148919.4 linkc.742+85G>T intron_variant Intron 5 of 5 ENST00000374882.8 NP_683720.2 P28062-1X5CMJ9
PSMB8NM_004159.5 linkc.730+85G>T intron_variant Intron 5 of 5 NP_004150.1 P28062-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PSMB8ENST00000374882.8 linkc.742+85G>T intron_variant Intron 5 of 5 1 NM_148919.4 ENSP00000364016.4 P28062-1

Frequencies

GnomAD3 genomes
AF:
0.363
AC:
55164
AN:
151916
Hom.:
10309
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.305
Gnomad AMI
AF:
0.478
Gnomad AMR
AF:
0.324
Gnomad ASJ
AF:
0.327
Gnomad EAS
AF:
0.230
Gnomad SAS
AF:
0.352
Gnomad FIN
AF:
0.381
Gnomad MID
AF:
0.506
Gnomad NFE
AF:
0.415
Gnomad OTH
AF:
0.372
GnomAD4 exome
AF:
0.399
AC:
494656
AN:
1240144
Hom.:
101164
AF XY:
0.398
AC XY:
249768
AN XY:
627534
show subpopulations
African (AFR)
AF:
0.306
AC:
8846
AN:
28892
American (AMR)
AF:
0.300
AC:
13271
AN:
44232
Ashkenazi Jewish (ASJ)
AF:
0.342
AC:
8501
AN:
24842
East Asian (EAS)
AF:
0.250
AC:
9672
AN:
38636
South Asian (SAS)
AF:
0.333
AC:
27235
AN:
81752
European-Finnish (FIN)
AF:
0.378
AC:
19008
AN:
50254
Middle Eastern (MID)
AF:
0.480
AC:
1784
AN:
3718
European-Non Finnish (NFE)
AF:
0.421
AC:
385421
AN:
914892
Other (OTH)
AF:
0.395
AC:
20918
AN:
52926
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
15679
31358
47038
62717
78396
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10704
21408
32112
42816
53520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.363
AC:
55156
AN:
152034
Hom.:
10304
Cov.:
32
AF XY:
0.358
AC XY:
26599
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.304
AC:
12621
AN:
41452
American (AMR)
AF:
0.323
AC:
4942
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.327
AC:
1137
AN:
3472
East Asian (EAS)
AF:
0.231
AC:
1193
AN:
5174
South Asian (SAS)
AF:
0.350
AC:
1686
AN:
4822
European-Finnish (FIN)
AF:
0.381
AC:
4025
AN:
10564
Middle Eastern (MID)
AF:
0.493
AC:
145
AN:
294
European-Non Finnish (NFE)
AF:
0.415
AC:
28197
AN:
67942
Other (OTH)
AF:
0.368
AC:
777
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1833
3666
5500
7333
9166
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
538
1076
1614
2152
2690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.240
Hom.:
564
Bravo
AF:
0.355
Asia WGS
AF:
0.273
AC:
951
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 14, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 46% of patients studied by a panel of primary immunodeficiencies. Number of patients: 44. Only high quality variants are reported. -

not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.5
DANN
Benign
0.79
PhyloP100
0.020
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2071627; hg19: chr6-32809223; API